On this page
Paramyotonia congenita
This condition causes episodes of muscle stiffness that can worsen with cold temperatures or exercise. It is present from birth or early childhood and typically affects voluntary muscles, though the severity can vary widely among individuals.
Overview
Paramyotonia congenita is a rare inherited condition that primarily affects the skeletal muscles, which are the muscles we can consciously control. Individuals with this condition experience myotonia, a phenomenon where muscles have difficulty relaxing after contraction, leading to temporary stiffness. Unlike some other myotonic disorders, the muscle stiffness in paramyotonia congenita often gets worse with exposure to cold temperatures or after repeated muscle use. It is a lifelong condition, but its symptoms can often be managed [PMID:33677353].
Symptoms typically become noticeable in infancy or early childhood. The severity and specific triggers for myotonia can differ significantly, even within the same family. Understanding the condition's triggers can help individuals manage their symptoms more effectively.
Symptoms & clinical features
The main symptom of paramyotonia congenita is myotonia, which is a prolonged muscle contraction. This can make it difficult to perform everyday tasks such as opening a hand after gripping an object or standing up quickly. The myotonia often worsens in cold environments, which is a key distinguishing feature of this condition [PMID:10714717]. For example, symptoms might be triggered by eating ice cream, swimming in cold water, or being in cold weather.
Another characteristic feature is 'paradoxical myotonia,' where repeated muscle movements can actually increase the stiffness, rather than warm up the muscles as might happen in other conditions. In some cases, prolonged or severe episodes of myotonia can lead to temporary muscle weakness. This weakness is usually transient but can be significant while it lasts.
Video: Genetics 101
Affected organs
Paramyotonia congenita primarily affects the skeletal muscles throughout the body. These are the voluntary muscles responsible for movement, such as those in the limbs, face, and neck. The muscles of the eyelids and tongue can also be affected, leading to temporary difficulties with speech or opening the eyes fully. The heart muscle and smooth muscles (such as those in the digestive system) are generally not affected by this condition.
Risks & severity
The severity of paramyotonia congenita can vary considerably. Some individuals might experience mild, infrequent stiffness, while others may have more frequent and debilitating episodes of myotonia and weakness. The condition is generally not progressive, meaning it does not typically worsen over time, though symptoms can fluctuate. The age of onset is usually in early childhood, but sometimes symptoms may only become apparent later in life.
This condition is not typically life-threatening. However, severe episodes of muscle weakness, especially if they affect muscles involved in breathing, could pose a risk, though this is rare. The main impact on quality of life comes from the unpredictable nature of symptoms and the need to avoid triggers. There is no increased risk of developing other medical conditions associated with paramyotonia congenita.
Genetic causes
Paramyotonia congenita is caused by pathogenic variants in the SCN4A gene. This gene provides instructions for making a protein component of a sodium channel. Sodium channels are crucial for the proper functioning of muscle cells. They regulate the flow of sodium ions into and out of muscle cells, which is essential for initiating and stopping muscle contractions.
When a pathogenic variant occurs in the SCN4A gene, it can alter the structure or function of the sodium channel. In paramyotonia congenita, these altered channels typically remain open for too long, allowing an excessive influx of sodium into the muscle cell. This prolonged sodium influx disrupts the electrical signals needed for muscle relaxation, leading to the characteristic stiffness and, in some cases, weakness [PMID:24260655].
- SCN4A sodium voltage-gated channel alpha subunit 4
Inheritance pattern
Paramyotonia congenita has an autosomal dominant inheritance pattern. This means that an individual only needs to inherit one copy of the altered SCN4A gene from one parent to develop the condition. If a parent has paramyotonia congenita, there is a 50% chance with each pregnancy that their child will also inherit the condition, regardless of the child's sex.
In some instances, a new pathogenic variant in the SCN4A gene can occur spontaneously in an individual with no family history of the condition. This is known as a 'de novo' variant. Affected individuals can then pass the condition on to their children in an autosomal dominant manner.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
Diagnosis & testing
Diagnosis of paramyotonia congenita often begins with a clinical assessment of symptoms and a detailed family history. Electrodiagnostic studies, such as electromyography (EMG), can be performed to detect the characteristic electrical activity associated with myotonia in the muscles. These tests help confirm the presence of myotonia and distinguish paramyotonia congenita from other muscle disorders.
Definitive diagnosis is confirmed through genetic testing, which looks for pathogenic variants in the SCN4A gene. Referrals for genetic testing are typically made by a neurologist or a clinical geneticist. In the UK, genetic testing for conditions like paramyotonia congenita falls under the NHS Genomic Medicine Service (GMS) pathways. The relevant R-codes (e.g., R156 'Myotonia and periodic paralysis') guide the testing process and help ensure the correct genetic analysis is performed.
Management & lifestyle
While there is no cure for paramyotonia congenita, management focuses on alleviating symptoms and preventing episodes. Individuals are generally advised to identify and avoid triggers, particularly cold temperatures. Lifestyle adjustments, such as wearing warm clothing or avoiding cold foods, can be very helpful.
Medications, such as mexiletine or carbamazepine, may be prescribed by a specialist to reduce the frequency and severity of myotonic episodes. These medications work by affecting the sodium channels in muscle cells. Any medication changes should always be discussed with a healthcare professional. Regular follow-up with a neurologist is important to monitor symptoms and adjust management strategies as needed. Genetic counsellors can also provide valuable information and support to individuals and families affected by the condition, helping them understand inheritance patterns and reproductive options.
UK care pathway
In the UK, individuals suspected of having paramyotonia congenita would typically be referred by their GP to a neurologist for specialist assessment. If a genetic cause is suspected, the neurologist or another specialist can refer for genetic testing through the NHS Genomic Medicine Service (GMS). This pathway ensures that appropriate genetic analysis, guided by specific R-codes like R156, is performed. Following a diagnosis, ongoing care involves specialist follow-up, and access to genetic counselling is available to discuss the implications for the individual and their family.
Frequently asked questions
What makes paramyotonia congenita different from other myotonic conditions?
A key difference is that symptoms of paramyotonia congenita typically worsen with exposure to cold temperatures and after repeated muscle movements (paradoxical myotonia), which is not always the case in other myotonic conditions.
Can paramyotonia congenita be passed on to children?
Yes, paramyotonia congenita is inherited in an autosomal dominant pattern. If you have the condition, each of your children has a 50% chance of inheriting the altered SCN4A gene and developing the condition.
Are there any specific activities I should avoid if I have paramyotonia congenita?
It is generally recommended to avoid activities or environments that trigger your symptoms, particularly prolonged exposure to cold temperatures. This might include cold weather, cold food/drinks, or swimming in unheated water. Your healthcare provider can give personalised advice.
Is paramyotonia congenita a progressive condition?
No, paramyotonia congenita is generally not considered a progressive condition. While symptoms can fluctuate and vary in severity, they typically do not worsen over a person's lifetime, and the muscle weakness is usually temporary.
What kind of specialist should I see for paramyotonia congenita?
Individuals with paramyotonia congenita are typically managed by a neurologist, who specialises in disorders of the nervous system and muscles. Genetic counsellors can also provide support and information regarding the genetic aspects of the condition.
References
- Heatwole CR, Moxley RT 3rd. The nondystrophic myotonias. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2007. PMID: 17395134
- Tamaoka A. Paramyotonia congenita and skeletal sodium channelopathy. Internal medicine (Tokyo, Japan). 2003. PMID: 14518660
- Jitpimolmard N, Matthews E, Fialho D. Treatment Updates for Neuromuscular Channelopathies. Current treatment options in neurology. 2020. PMID: 32848354